An efficient synthesis of indolo[2,3-b]quinoline guanidine derivatives with their in vitro and in vivo study
作者:Katarzyna Sidoryk、Marta Świtalska、Piotr Rózga、Joanna Wietrzyk、Iwona Bujak、Bartłomiej Żerek、Łukasz Kaczmarek、Marcin Cybulski
DOI:10.1007/s00044-017-2028-1
日期:2017.12
verifying the efficacy of common guanylation reagents in order to obtain the guanidine derivatives of indolo[2,3-b]quinoline has been performed. As a result, a high-yield procedure using N,N′-di-Boc-N′′-triflylguanidine was applied to synthesize the guanidine derivative of indolo[2,3-b]quinoline 1 in a gram scale for specific in vitro and in vivo biological research. Extensive studies on the antiproliferative
为了验证吲哚并[2,3-b]喹啉的胍衍生物,通过验证常用的胍化试剂的功效来优化胍基化工艺。其结果是,使用高产量过程Ñ,Ñ ' -二-制备Boc- Ñ ''-triflylguanidine施加到合成吲哚并[2,3-B]的胍衍生物的喹啉1在一克规模为特定的体外和体内生物学研究。关于八种人类肿瘤细胞系的抗增殖活性的广泛研究已经完成。化合物1显示出针对A549肺腺癌和MCF7乳腺癌细胞系的最高活性。因此,1在小鼠模型中评估了其对4T1乳腺癌和KLN205鼠肺癌的体内抗癌活性。在KLN205模型中观察到抗癌作用,在20 mg / kg剂量下具有37%的肿瘤生长抑制作用。1的抗癌活性与环磷酰胺在100 mg / kg的剂量下可抑制鼠肺肿瘤生长的27-43%相当。1次入院后的生化研究,包括测量血液参数如丙氨酸转氨酶,天冬氨酸转氨酶,乳酸脱氢酶,尿素和肌酐。